Supplementary appendix

Size: px
Start display at page:

Download "Supplementary appendix"

Transcription

1 Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Goedhals D, Rossouw I, Hallbauer U, Mamabolo M, de Oliveira T. The tainted milk of human kindness. Lancet 2012; 380: 702.

2 SUPPLEMENTARY INFORMATION: 1. Supplementary Notes: Background of this transmission case: The case infant was born by normal vaginal delivery at 37 weeks gestation at a midwife clinic on 29 June The 19 year old mother (Gravida 2 Para 2) had attended antenatal visits at the local clinic and her clinical chart showed her to be RPR and HIV negative. The 2.9kg baby was referred directly to a secondary hospital with transient tachypnea of the newborn. She was treated with supportive oxygen, fluids and antibiotics, and blood gases and infective markers were found to be normal. Breastfeeding was started during the hospital admission and the infant was discharged after 6 days in a stable condition. The child was then admitted to the Pediatric Intensive Care Unit at Pelonomi Hospital, Bloemfontein, South Africa on 11 September 2009 with a two day history of rapid breathing, coughing, weakness and lethargy. Clinical examination showed a respiratory rate of 75 breaths/minute, heart rate of 157/minute, and temperature of 35.8 C. Oxygen saturation was 34% on room air and 98% on supplemental oxygen administered via a head box. The infant appeared to be anemic, cyanosed and had palpable axillary lymphnodes. The respiratory examination showed nasal flaring, subcostal recession and bilateral coarse crepitations on auscultation. Laboratory testing confirmed a normochromic, normocytic anemia (Hb 9.8 g/dl) and neutrophil leukocytosis, with a C- reactive protein of 70.1 mg/l (reference range: 0-10 mg/l) and lactate dehydrogenase of 978 U/l (reference range: U/l) on the day of admission. Antibiotics including intravenous cotrimoxazole were administered, however, microbiological testing of cerebrospinal fluid and blood cultures

3 showed no growth, while a urine culture showed no significant organisms. Indirect immunofluorescent antibody testing for Pneumocystis jirovecii was negative, but cytomegalovirus (CMV) was isolated on shell vial culture of a respiratory sample and a CMV viral load of copies/ml was found in a paired blood sample. She was successfully weaned off oxygen therapy after eight days. An HIV ELISA taken on 11 September 2009, as well as a confirmatory sample on 16 September 2009, tested positive on the infant. An HIV DNA PCR was then submitted on 17 September 2009 which was also found to be positive. She had a CD4+ T cell count of 2189 x10 6 cells/l (40% of lymphocytes) and antiretroviral therapy was started. At the six month follow- up visit, the HIV viral load was undetectable and the CD4+ T cell count was 3378 x10 6 cells/l (29.4% of lymphocytes). An HIV ELISA test (combination antibody/antigen assay) was performed on the mother on 19 September 2009, which confirmed the history obtained from the antenatal clinic that she was HIV negative. The aunt and her own 117 day old child were subsequently found to be HIV positive by HIV ELISA (submitted 12 October 2009) and HIV DNA PCR (submitted 23 October 2009) respectively. Laboratory records subsequently confirmed that the aunt had tested HIV ELISA positive in February 2008 and a previous child of hers had tested HIV DNA PCR positive at that stage. It cannot be confirmed whether the aunt was counselled regarding this result, but she claimed that she was not aware of her HIV status. The characteristics of each individual involved are summarized in table 1. EDTA blood samples were obtained from the aunt, cousin and case infant on 27 November The samples were centrifuged at 4000 rpm for 10 min and the plasma was stored in cryotubes at - 80 C until testing. Informed consent was

4 signed by the mother and aunt to publish details of the case and laboratory testing pertaining to themselves and their respective children. Ethics approval was obtained from the University of the Free State Ethics Committee (ETOVS 220/09). 2. Supplementary methods: RNA Extraction, PCR Amplification and Sequencing. RNA was extracted from plasma using the QIAmp Viral RNA kit (Qiagen, Heiden, Germany). Briefly 140µl of plasma was added to lysis buffer containing carrier RNA and loaded onto a column. The spin protocol was followed using a microcentrifuge and after washing the sample was eluted in 40µl of nuclease free water. Sequencing was performed using the TRUGENE HIV- 1 Genotyping kit according to the manufacturer s instructions (Visible Genetics, Inc). From the extracted RNA, 17µl was mixed with RT- PCR reagents including buffer, primers, dntps, dithiothreitol, RNAse inhibitor, reverse transcriptase enzyme, and Taq DNA polymerase. The RT- PCR primers used in the kit are designed to amplify the entire protease (codons 1-99) and codons of reverse transcriptase. The reverse transcriptase reaction involves an incubation at 90 C for 2 min, followed by 50 C for 5 min. Following the addition of reverse transcriptase enzyme, the reaction continued for a further 55 min before ending at 94 C for 2 min. DNA amplification followed with the following cycling conditions: 20 cycles of 94 C for 30 s, 57 C for 30 s, and 68 C for 2 min; then 17 cycles of 94 C for 30 s, 60 C for 30 s, and 68 C for 2.5 min; lastly 1 incubation of 68 C for 7 min a 4 C hold. 5µl of the RT- PCR product from each specimen was used in each of 16 sequencing reactions. This is based on the CLIP principle 1 which uses four pairs of primers, namely two pairs that sequence protease and one pair each for the beginning

5 and middle of reverse transcriptase. Four sequencing reactions were run for each segment, using one of four dideoxy terminators (ddatp, ddctp, ddgtp, and ddttp) and at least two primers. The forward and reverse primers were labeled with fluorescent dyes (Cy5 and Cy5.5 respectively). The cycling conditions were as follows: 30 cycles of 94 C for 20 s, 56 C for 20 s, and 70 C for 1.5 min; followed by 70 C for 5 min. The CLIP sequencing products were analyzed using Surefill 6% sequencing polyacrylamide gel cartridges and Microcel cassettes, which underwent gel electrophoresis at 2000 V for 50 min on the Long Read Tower Sequencers. 2 Sequence data analysis Sequence data was analysed using the OpenGene system software. The forward and reverse sequences are combined and compared to the sequence of HIV- 1 LAI and a mutated reference sequence in order to determine the presence of all mutations, including drug resistant mutations. Manual editing was limited to bases in positions known to be associated with resistance mutations and bases that were discordant between the two sequencing reactions. The edited sequences were exported from the software in fasta format for analysis. 2 Reference Sequences and Alignment The first reference dataset contained HIV- 1 subtype C sequences isolated in the Free State Province of South Africa. This dataset was obtained from the paper by Huang and colleagues. 3 In this paper, the authors have sequenced 425 highly active antiretroviral therapy (HAART)- naïve HIV- 1 positive patients from the Free State province in South Africa. In total, 108 reference strains with highest BLAST search similarity score to the case were chosen for phylogenetic

6 construction. The alignment was 880 nucleotide base pairs in length and spanned the protease amino- acid positions 4 to 99 and the reverse transcriptase positions 38 to 235. The second dataset for HIV- 1 subtype C was obtained from the HIV Sequence Database at Los Alamos ( and from GenBank ( In total 1,379 reference strains were chosen for the analysis. All of the sequences selected spanned the 880bp region used in the first analysis. These include HIV- 1 subtype C strains from Argentina (4), BE (9), Brazil (24), Botswana (137), CD (10), CH (1), CM (1), CN (2), CZ (11), DE (1), DJ (1), DK (18), ER (2), ES (1), ET (11), France (7), GA (1), GE (1), Israel (6), India (20), Italy (14), Kenya (3), LC (1), MM (1), Malawi (146), Nigeria (1), Portugal (1), SD (11), SE (40), SN (7), Somalia (1), Tanzania (22), UA (3), Uganda (10), United States of America (6), Uruguay (1), Yemen (1) and South Africa (797). All of the reference sequences from the first and second dataset and the three case sequences were subtyped using the Rega HIV- 1 Subtyping Tool version ,5 All sequences were confirmed as HIV- 1 subtype C. The case sequences were then aligned with the two reference datasets using ClustalW 6 and subsequently edited by hand using Se- Al The consensus HIV- 1 subtype B sequence from the Los Alamos Database was added to both datasets and was used as the outgroup in the phylogenetic analysis. Phylogenetic Analysis First dataset (111 sequences: 3 cases, 107 Free State and 1 reference subtype B): The best fitting nucleotide substitution model was evaluated for the first dataset using hierarchical likelihood ratio tests the methodology implemented in ModelTest. 8 The model chosen for the HIV- 1 alignment was GTR+G (general time

7 reversible model with gamma distributed among- site rate heterogeneity). Maximum likelihood (ML) phylogeny was estimated for the first dataset (smaller dataset, which contained 111 sequences) under the abovementioned models, starting with a NJ starting tree and using the TBR (tree bisection and reconnection) and SPR (subtree pruning and regrafting) heuristic search algorithms. The final ML phylogeny is shown in Supplementary Figure 1. Calculations were performed with PAUP* 4.0b10. 9 Statistical support for ML phylogeny structures was evaluated by bootstrapping analysis of the original sequence alignments (1000 NJ replicates). The tree was rooted using the HIV- 1 subtype B consensus reference dataset and presented using the program FigTree. 10 The model parameter estimations and ML assessment took 123 hours and 16 minutes to be computed (5,14 days), using 2 x 2.66 GHz 6- Core Intel Xeon MacPro computer. Maximum likelihood parameters estimates are seen on supplementary table 2. Bayesian estimates of phylogeny were obtained using MrBayes 11, under the GTR+G model for the first HIV- 1 subtype C alignment. Four Markov Chain Monte Carlo (MCMC) runs were calculated independently. Each MCMC run was 10,000,000 steps long and was sampled every 1000 steps, with 0.2 as the temperature parameter. The average standard deviation of split frequencies was calculated for the four chains to check for convergence. Subsequently, the Effective Sampling Size (ESS) was calculated by combining the output of the four runs using Tracer, excluding an initial burn- in of 10% for each chain. 12 The ESS values were >100, indicating a sufficient level of sampling. The four runs were combined using LogCombiner. 13 A final Bayesian majority- rule consensus tree was obtained with the combined runs using TreeAnnotator. 14 The tree was rooted using the HIV- 1 subtype B consensus reference dataset and presented

8 using the program FigTree. 10 The model parameter estimations and four Bayesian chains assessment took 72 hours and 32 minutes to be computed (3,02 days), Bayesian parameters estimates are seen on supplementary table Z. Second dataset (1,379 sequences; 3 cases, 1375 Subtype C worldwide reference sequences and 1 reference subtype B): Given the number of sequences on this alignment, phylogenetic reconstruction was done with the use of neighbor- joining (NJ) and minimum evolution (ME) methods. These are the two most appropriate methods for large phylogenies construction and assessment. The assessment of the phylogenies was performed with 1,000 bootstrap resampling. Neighbor- joining (NJ) phylogeny was estimated under the GTR+G evolutionary model. Model parameters were estimated using a maximum likelihood framework and a NJ starting tree. Model parameters were estimated using three rounds, with start values from the previous round. The final model estimates were RMatrix (1.37, 9.12, 0.80, 0.75, 9.12, 1.0), Gamma rate variation across sites alpha shape value (0.5). These were used for the construction of the NJ phylogeny. Calculations were performed with PAUP* 4.0b10. 9 Statistical support for NJ phylogeny structures was evaluated by bootstrapping analysis of the original sequence alignments (1000 NJ replicates). The model parameter estimations and NJ assessment took 3,5 days, using 2 x 2.66 GHz 6- Core Intel Xeon MacPro computer. The final NJ phylogeny is shown in Supplementary Figure 3. Minimum evolution (ME) phylogeny was estimated under the F84 model of evolution with Gamma rate variation across sites The reason to not use the GTR was due to the absence of this model in FastMe 15, the software used for the

9 ME phylogeny construction. The ME phylogeny was constructed with Nearest Neighbor Interchange (NNI) algorithm. NNI is a heuristic algorithm for searching treespace. During each round, the best tree is retained, in total 718 rounds were necessary for the construction of the final tree, which is shown in Supplementary Figure 4. The model parameter estimations and ME assessment took 21 hours and 21 minutes. The tree was assessed with 1,000 bootstrap replicates. It is important to note that the phylogenetic methods used in this analysis cannot be used to determine the direction of transmission, and cannot exclude horizontal transmission between the two children, or transmission from the infant- case to the aunt. However, this may be an unlikely event and the fact that the aunt breastfed her niece suggests that transmission is more likely to have happened via breastfeeding. The possibility that the aunt gave birth to both children and that one of them was given to her sister is excluded due to the dates of birth of the children, which are separated by 44 days. Supplementary Material References: 1. Yager, T. D., Baron L., Batra R., et al. High performance DNA sequencing, and the detection of mutations and polymorphisms, on the Clipper sequencer. Electrophoresis 20: (1999). 2. Grant RM, Kuritzkes DR, Johnson VA, et al. Accuracy of the TRUGENE HIV- 1 genotyping kit. J Clin Microbiol 41: (2003). 3. Huang K.H., Goedhals D., Fryer H., et al. Prevalence of HIV type- 1 drug- associated mutations in pre- therapy patients in the Free State, South Africa. Antivir Ther.,x14(7): (2009).

10 4. De Oliveira, T., Deforche, K., Cassol, S., et al. An automated genotyping system for analysis of HIV- 1 and other microbial sequences. Bioinformatics 21: (2005). 5. Alcantara L.C.J., Cassol S., Libin P., et al. A Standardized Framework for Accurate, High- throughput Genotyping of Recombinant and Non- recombinant Viral Sequences. Nucleic Acids Research, 1-9, doi: /nar/gkp455 (2009). 6. Thompson, J.D., Higgins, D.G., Gibson, T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position- specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, (1994). 7. Rambaut, A Se- Al: Sequence Alignment Editor. Available at (1996) 8. Posada D., Crandall K.A. MODELTEST: testing the model of DNA substitution. Bioinformatics. 14, (1998). 9. Swofford, D.L. PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods). Version 4. Sinauer Associates, Sunderland, Massachusetts (2003). 10. Rambaut, A. FigTree. Available from (2011). 11. Ronquist, F., Huelsenbeck, J.P. MRBAYES 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19, (2003) 12. Rambaut, A., Drummond, A.J. Tracer. Available from (2011)

11 13. Rambaut, A., Drummond, A.J. & Marc Suchard. LogCombiner. Available from (2011) 14. Rambaut, A., Drummond, A.J. & Marc Suchard. TreeAnnotator. Available from (2011) 15. Desper R., Gascuel O Fast and accurate phylogeny reconstruction algorithms based on the minimum- evolution principle. FastME algorithms (balanced and OLS GME, balanced and OLS NNI, balanced and OLS branch length optimization): Journal of Computational Biology. 9(5):

12 Supplementary Table 1: Individual characteristics Infant-Case Mother Aunt Infant- Cousin DOB 29/06/ /11/ /09/ /05/2009 Age (when 74 days 19 years 25 years 117 days seen by clinicians in Sept 2009) HIV ELISA Positive Negative Positive Not done test HIV PCR test Positive Not done Not done Positive HIV Yes No Yes Yes genotyping On ART No Not applicable No No when first seen

13 Supplementary Table 2 - Maximum Likelihood (ML) and Bayesian parameters for the First dataset (111 sequences: 3 cases, 107 Free State and 1 reference subtype B). Method Model LnL R- Matrix Alpha PInv Maximum GTR+G+I , 10.16, likelihood 0.86, 0.84, Bayesian run1 Bayesian run2 Bayesian run3 Bayesian run4 Bayesian combined GTR+G+I , 0.38, 0.04, 0.02, 0.41, 0.04 GTR+G+I , 0.38, 0.04, 0.02, 0.44, 0.04 GTR+G+I , 0.38, 0.04, 0.02, 0.44, 0.04 GTR+G+I , 0.38, 0.04, 0.02, 0.44, 0.04 GTR+G+I , 0.38, 0.04, 0.02, 0.44,

14 Supplementary Figure 1 Maximum likelihood phylogenetic tree showing the relationship among the three (n=3) transmission case s sequences and other HIV- 1 subtype C sequences from the Free State (n=107). The tree is rooted with a HIV- 1 Subtype B reference sequence (BRef). The red branches and red text represent sequences from the transmission cases and their bootstrap support values, respectively.

15 Supplementary Figure 2 HIV- 1 Consensus Majority Rule Bayesian Tree showing posterior probabilities for the internal branch of the tree that connect the three case sequences. Sequences from the transmission case are shown in red; the tree is rooted with the HIV- 1 subtype B reference sequence; the remaining 107 sequences are the most similar HIV- 1 subtype C sequences in the Free State Province, South Africa.

16 Supplementary Figure 3 Neighbor- Joining (NJ) phylogenetic tree showing the relationship among the three (n=3) transmission case s sequences and other HIV- 1 subtype C sequences (n=1375). The tree is rooted with a HIV- 1 Subtype B reference sequence (BRef). The red branches and red text represent sequences from the transmission cases and their bootstrap support v alues, respectively.

17 Supplementary Figure 4 Minimum evolution phylogenetic tree showing the relationship among the three (n=3) transmission case s sequences and other HIV- 1 subtype C sequences (n=1375). The tree is rooted with a HIV- 1 Subtype B reference sequence (BRef). The red branches and red text represent sequences from the transmission cases and their bootstrap support v alues, respectively.

The BLAST search on NCBI ( and GISAID

The BLAST search on NCBI (    and GISAID Supplemental materials and methods The BLAST search on NCBI (http:// www.ncbi.nlm.nih.gov) and GISAID (http://www.platform.gisaid.org) showed that hemagglutinin (HA) gene of North American H5N1, H5N2 and

More information

A new human immunodeficiency virus derived from gorillas

A new human immunodeficiency virus derived from gorillas A new human immunodeficiency virus derived from gorillas Jean-Christophe Plantier, Marie Leoz, Jonathan E Dickerson, Fabienne De Oliveira, François Cordonnier, Véronique Lemée, Florence Damond, David L

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Rodger AJ, Cambiano V, Bruun T, et al; PARTNER Study Group. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIVpositive partner

More information

High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity

High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1635 1641 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.01478-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. High Failure

More information

Product # Kit Components

Product # Kit Components 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com Pneumocystis jirovecii PCR Kit Product # 42820 Product Insert Background Information

More information

Diagnostic Methods of HBV and HDV infections

Diagnostic Methods of HBV and HDV infections Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection

More information

Molecular Diagnosis Future Directions

Molecular Diagnosis Future Directions Molecular Diagnosis Future Directions Philip Cunningham NSW State Reference Laboratory for HIV/AIDS & Molecular Diagnostic Medicine Laboratory, SydPath St Vincent s Hospital Sydney Update on Molecular

More information

COMPARATIVE ANALYSIS OF BIOINFORMATICS TOOLS USED IN HIV-1 STUDIES

COMPARATIVE ANALYSIS OF BIOINFORMATICS TOOLS USED IN HIV-1 STUDIES The 10 th Conference for Informatics and Information Technology (CIIT 2013) COMPARATIVE ANALYSIS OF BIOINFORMATICS TOOLS USED IN HIV-1 STUDIES Daniel Kareski Navayo technologies Skopje, Macedonia Nevena

More information

Phylogenetic Methods

Phylogenetic Methods Phylogenetic Methods Multiple Sequence lignment Pairwise distance matrix lustering algorithms: NJ, UPM - guide trees Phylogenetic trees Nucleotide vs. amino acid sequences for phylogenies ) Nucleotides:

More information

Distinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement

Distinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement Distinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement Leander Schietgat 1, Kristof Theys 2, Jan Ramon 1, Hendrik Blockeel 1, and Anne-Mieke Vandamme

More information

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons

More information

Evaluation of Dried Blood Spots (DBS) for Human Immunodeficiency Virus (HIV-1) Drug Resistance Testing

Evaluation of Dried Blood Spots (DBS) for Human Immunodeficiency Virus (HIV-1) Drug Resistance Testing Evaluation of Dried Blood Spots (DBS) for Human Immunodeficiency Virus (HIV-1) Drug Resistance Testing Dawit Assefa 2, Woldaregay E.Abegaz 3, Teferi Gedif 2, Belete Tegbaru 1, Dereje Teshome 1, Tesfaye

More information

Norgen s HIV Proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad T1000 Cycler

Norgen s HIV Proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad T1000 Cycler 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com HIV Proviral DNA PCR Kit Product# 33840 Product Insert Intended

More information

RNA PCR, Proviral DNA and Emerging Trends in Infant HIV Diagnosis

RNA PCR, Proviral DNA and Emerging Trends in Infant HIV Diagnosis RNA PCR, Proviral DNA and Emerging Trends in Infant HIV Diagnosis 1 B R E N D A N M C M U L L A N I N F E C T I O U S D I S E A S E S, S Y D N E Y C H I L D R E N S H O S P I T A L S C H O O L O F W O

More information

Principles of phylogenetic analysis

Principles of phylogenetic analysis Principles of phylogenetic analysis Arne Holst-Jensen, NVI, Norway. Fusarium course, Ås, Norway, June 22 nd 2008 Distance based methods Compare C OTUs and characters X A + D = Pairwise: A and B; X characters

More information

(ii) The effective population size may be lower than expected due to variability between individuals in infectiousness.

(ii) The effective population size may be lower than expected due to variability between individuals in infectiousness. Supplementary methods Details of timepoints Caió sequences were derived from: HIV-2 gag (n = 86) 16 sequences from 1996, 10 from 2003, 45 from 2006, 13 from 2007 and two from 2008. HIV-2 env (n = 70) 21

More information

AIDS - Knowledge and Dogma. Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/ , Vienna, Austria

AIDS - Knowledge and Dogma. Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/ , Vienna, Austria AIDS - Knowledge and Dogma Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/17 2010, Vienna, Austria Reliability of PCR to detect genetic sequences from HIV Juan Manuel

More information

Contents. lessmore. 1 of 11 6/2/ :06 PM

Contents. lessmore. 1 of 11 6/2/ :06 PM 1 of 11 6/2/2010 12:06 PM Background Since its initial detection in April 2009, the A/H1N1pdm influenza virus has spread rapidly in humans, with over 5,700 human deaths. However, little is known about

More information

WHO recommendations. Diagnostic testing in infants

WHO recommendations. Diagnostic testing in infants WHO recommendations Diagnostic testing in infants Recommendations 2- testing in infants Intervention Reco QoE Comment At or around 6 weeks of age is most efficient time at which to perform a viral test

More information

Norgen s HIV proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad icycler

Norgen s HIV proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad icycler 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com HIV Proviral DNA PCR Kit Product # 33840 Product Insert Background Information

More information

Cytomegalovirus (CMV) End-Point PCR Kit Product# EP36300

Cytomegalovirus (CMV) End-Point PCR Kit Product# EP36300 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com Cytomegalovirus (CMV) End-Point PCR Kit Product# EP36300 Product

More information

Kit Components Product # EP42720 (24 preps) MDx 2X PCR Master Mix 350 µl Cryptococcus neoformans Primer Mix 70 µl Cryptococcus neoformans Positive

Kit Components Product # EP42720 (24 preps) MDx 2X PCR Master Mix 350 µl Cryptococcus neoformans Primer Mix 70 µl Cryptococcus neoformans Positive 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com Cryptococcus neoformans End-Point PCR Kit Product# EP42720 Product

More information

Rajesh Kannangai Phone: ; Fax: ; *Corresponding author

Rajesh Kannangai   Phone: ; Fax: ; *Corresponding author Amino acid sequence divergence of Tat protein (exon1) of subtype B and C HIV-1 strains: Does it have implications for vaccine development? Abraham Joseph Kandathil 1, Rajesh Kannangai 1, *, Oriapadickal

More information

Phylodynamics of HIV-1 Subtype B among the Men- Having-Sex-with-Men (MSM) Population in Hong Kong

Phylodynamics of HIV-1 Subtype B among the Men- Having-Sex-with-Men (MSM) Population in Hong Kong Phylodynamics of HIV-1 Subtype B among the Men- Having-Sex-with-Men (MSM) Population in Hong Kong Jonathan Hon-Kwan Chen 1,3, Ka-Hing Wong 2, Kenny Chi-Wai Chan 2, Sabrina Wai-Chi To 1, Zhiwei Chen 3,

More information

HIV-1 subtype C in Karonga District, Malawi. Simon Travers

HIV-1 subtype C in Karonga District, Malawi. Simon Travers HIV-1 subtype C in Karonga District, Malawi Simon Travers HIV-1; closely related to HIV found in chimps HIV-2; closely related to HIV found in mangabys Worldwide Distribution of HIV-1 group M subtypes

More information

HIV-1 Genemer Detection Kit Ready to Use Amplification Kit for HIV-1 Specific DNA Fragment Analysis

HIV-1 Genemer Detection Kit Ready to Use Amplification Kit for HIV-1 Specific DNA Fragment Analysis Product Manual HIV-1 Genemer Detection Kit Ready to Use Amplification Kit for HIV-1 Specific DNA Fragment Analysis For research use only. Not for use in diagnostic procedures for clinical purposes Catalog

More information

Hepatitis B Virus Genemer

Hepatitis B Virus Genemer Product Manual Hepatitis B Virus Genemer Primer Pair for amplification of HBV Viral Specific Fragment Catalog No.: 60-2007-10 Store at 20 o C For research use only. Not for use in diagnostic procedures

More information

Molecular Epidemiology of HBV Genotypes Circulating In Acute Hepatitis B Patients In The Campania Region

Molecular Epidemiology of HBV Genotypes Circulating In Acute Hepatitis B Patients In The Campania Region Molecular Epidemiology of HBV Genotypes Circulating In Acute Hepatitis B Patients In The Campania Region Caterina Sagnelli 1, Massimo Ciccozzi 2,3, Mariantonietta Pisaturo 4, Gianguglielmo Zehender 5,

More information

For purification of viral DNA and RNA from a wide range of sample materials

For purification of viral DNA and RNA from a wide range of sample materials QIAamp virus kits For purification of viral DNA and RNA from a wide range of sample materials Automatable on QIAGEN s proven QIAamp Kits set the standard for purification of viral DNA and RNA. QIAamp virus

More information

Multiple sequence alignment

Multiple sequence alignment Multiple sequence alignment Bas. Dutilh Systems Biology: Bioinformatic Data Analysis Utrecht University, February 18 th 2016 Protein alignments We have seen how to create a pairwise alignment of two sequences

More information

Human Immunodeficiency Virus-1 (HIV-1) Genemer. Primer Pair for amplification of HIV-1 Specific DNA Fragment

Human Immunodeficiency Virus-1 (HIV-1) Genemer. Primer Pair for amplification of HIV-1 Specific DNA Fragment Product Manual Human Immunodeficiency Virus-1 (HIV-1) Genemer Primer Pair for amplification of HIV-1 Specific DNA Fragment Catalog No.: 60-2002-10 Store at 20 o C For research use only. Not for use in

More information

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Diagnostic Methods of HBV infection Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Hepatitis B-laboratory diagnosis Detection of HBV infection involves

More information

WHO Prequalification of Diagnostics Programme PUBLIC REPORT

WHO Prequalification of Diagnostics Programme PUBLIC REPORT WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, version 2.0 (TaqMan 48) Number: PQDx 0126-046-00 Abstract The COBAS AmpliPrep/COBAS TaqMan

More information

Recommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness

Recommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness World Health Organization Recommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness General information Highly pathogenic avian influenza (HPAI)

More information

Phylogenesis and Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

Phylogenesis and Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection 22 The Open Virology Journal, 2011, 5, 22-26 Open Access Phylogenesis and Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection Massimo Ciccozzi 1, Muhammed Babakir-Mina 2,3, Alessandra

More information

Instructions for Use. RealStar Influenza S&T RT-PCR Kit /2017 EN

Instructions for Use. RealStar Influenza S&T RT-PCR Kit /2017 EN Instructions for Use RealStar Influenza S&T RT-PCR Kit 3.0 01/2017 EN RealStar Influenza S&T RT-PCR Kit 3.0 For research use only! (RUO) 163003 INS-163000-EN-S02 96 01 2017 altona Diagnostics GmbH Mörkenstr.

More information

Instructions for Use. RealStar Influenza Screen & Type RT-PCR Kit /2017 EN

Instructions for Use. RealStar Influenza Screen & Type RT-PCR Kit /2017 EN Instructions for Use RealStar Influenza Screen & Type RT-PCR Kit 4.0 05/2017 EN RealStar Influenza Screen & Type RT-PCR Kit 4.0 For research use only! (RUO) 164003 INS-164000-EN-S01 96 05 2017 altona

More information

Trends in molecular diagnostics

Trends in molecular diagnostics Trends in molecular diagnostics Detection of target genes of interest Quantification Infectious diseases HIV Hepatitis C & B TB / MAC Cytomegalovirus Herpes simplex Varicella zoster CT/GC HPV Profiling

More information

Reverse transcriptase and protease inhibitor resistant mutations in art treatment naïve and treated hiv-1 infected children in India A Short Review

Reverse transcriptase and protease inhibitor resistant mutations in art treatment naïve and treated hiv-1 infected children in India A Short Review pissn 2349-2910 eissn 2395-0684 REVIEW Reverse transcriptase and protease inhibitor resistant mutations in art treatment naïve and treated hiv-1 infected children in India A Short Review Dinesh Bure, Department

More information

Analysis of HIV-1 Resistance Mutations from various Compartments of the Peripheral Blood in Patients with Low-Level Viremia

Analysis of HIV-1 Resistance Mutations from various Compartments of the Peripheral Blood in Patients with Low-Level Viremia Andrea Freystetter / Christian Paar / Herbert Stekel / Jörg Berg Analysis of HIV-1 Resistance Mutations from various Compartments of the Peripheral Blood in Patients with Low-Level Viremia 107 - Translationale

More information

Multi-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis

Multi-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin

More information

For Research Use Only Ver

For Research Use Only Ver INSTRUCTION MANUAL ZR Viral RNA Kit Catalog Nos. R1034 & R1035 Highlights Quick, 5-minute recovery of viral RNA from plasma, serum and other samples. Omits the use of organic denaturants and proteases.

More information

Name: Due on Wensday, December 7th Bioinformatics Take Home Exam #9 Pick one most correct answer, unless stated otherwise!

Name: Due on Wensday, December 7th Bioinformatics Take Home Exam #9 Pick one most correct answer, unless stated otherwise! Name: Due on Wensday, December 7th Bioinformatics Take Home Exam #9 Pick one most correct answer, unless stated otherwise! 1. What process brought 2 divergent chlorophylls into the ancestor of the cyanobacteria,

More information

HIV-1 Viral Load Real Time (RG)

HIV-1 Viral Load Real Time (RG) -1 Viral Load Real Time (RG) Real Time RT-PCR type 1 RNA quantification assay MSP Reg. pending Valdense 3616. 11700. Montevideo. Uruguay. phone (598) 2 336 83 01. Fax (598) 2 336 71 60. Info@atgen.com.uy

More information

Microchip Technology. Xuanhong Cheng Materials Science and Engineering

Microchip Technology. Xuanhong Cheng Materials Science and Engineering Microchip Technology for Global l Health Diagnostics Xuanhong Cheng Materials Science and Engineering Bioengineering Microchip Technology Basic Water for Medicine Supply Overview of Presentation 1 Global

More information

Mapping Evolutionary Pathways of HIV-1 Drug Resistance. Christopher Lee, UCLA Dept. of Chemistry & Biochemistry

Mapping Evolutionary Pathways of HIV-1 Drug Resistance. Christopher Lee, UCLA Dept. of Chemistry & Biochemistry Mapping Evolutionary Pathways of HIV-1 Drug Resistance Christopher Lee, UCLA Dept. of Chemistry & Biochemistry Stalemate: We React to them, They React to Us E.g. a virus attacks us, so we develop a drug,

More information

altona RealStar Instructions for Use RealStar CMV PCR Kit /2017 EN DIAGNOSTICS

altona RealStar Instructions for Use RealStar CMV PCR Kit /2017 EN DIAGNOSTICS altona DIAGNOSTICS Instructions for Use RealStar CMV PCR Kit 1.2 08/2017 EN RealStar RealStar CMV PCR Kit 1.2 For research use only! (RUO) 021202 INS-021200-EN-S01 48 08 2017 altona Diagnostics GmbH Mörkenstr.

More information

SUPPLEMENTARY METHODS. RNA extraction, cdna synthesis and PCR amplification. Since most

SUPPLEMENTARY METHODS. RNA extraction, cdna synthesis and PCR amplification. Since most SUPPLEMENTARY METHODS RNA extraction, cdna synthesis and PCR amplification. Since most patients enrolled in the study had periods of low viral loads in plasma, a sensitive RNA extraction method was used.

More information

HEPATITIS C VIRUS GENOTYPING IN CHRONIC HEPATITIS C PATIENTS

HEPATITIS C VIRUS GENOTYPING IN CHRONIC HEPATITIS C PATIENTS HEPATITIS C VIRUS GENOTYPING IN CHRONIC HEPATITIS C PATIENTS I. Qattan Centres for Hepatology, Royal Free & University College Medical School, London V. Emery Department of Virology, Royal Free & University

More information

Laboratory diagnosis of congenital infections

Laboratory diagnosis of congenital infections Laboratory diagnosis of congenital infections Laboratory diagnosis of HSV Direct staining Tzanck test Immunostaining HSV isolation Serology PCR Tzanck test Cell scrape from base of the lesion smear on

More information

Immune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa

Immune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa African Journal of Biotechnology Vol. 10(24), pp. 4784-4793, 6 June, 2011 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB10.560 ISSN 1684 5315 2011 Academic Journals Full Length

More information

To test the possible source of the HBV infection outside the study family, we searched the Genbank

To test the possible source of the HBV infection outside the study family, we searched the Genbank Supplementary Discussion The source of hepatitis B virus infection To test the possible source of the HBV infection outside the study family, we searched the Genbank and HBV Database (http://hbvdb.ibcp.fr),

More information

PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist

PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist PAEDIATRIC HIV INFECTION Dr Ashendri Pillay Paediatric Infectious Diseases Specialist Paediatric HIV Infection Epidemiology Immuno-pathogenesis Antiretroviral therapy Transmission Diagnostics Clinical

More information

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere q HIV-1/2 Detect WHO reference number: PQDx

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere q HIV-1/2 Detect WHO reference number: PQDx WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT Product: Alere q HIV-1/2 Detect WHO reference number: PQDx 0226-032-00 Alere q HIV-1/2 Detect with product codes 270110050, 270110010 and 270300001,

More information

NJMerge: A generic technique for scaling phylogeny estimation methods and its application to species trees Supplementary Materials

NJMerge: A generic technique for scaling phylogeny estimation methods and its application to species trees Supplementary Materials NJMerge: A generic technique for scaling phylogeny estimation methods and its application to species trees Supplementary Materials Erin K. Molloy 1[ 1 5553 3312] and Tandy Warnow 1[ 1 7717 3514] Department

More information

The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa

The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa Sharma et al. BMC Infectious Diseases (2017) 17:95 DOI 10.1186/s12879-017-2184-4 RESEARCH ARTICLE The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa

More information

Origins and evolutionary genomics of the novel avian-origin H7N9 influenza A virus in China: Early findings

Origins and evolutionary genomics of the novel avian-origin H7N9 influenza A virus in China: Early findings Origins and evolutionary genomics of the novel 2013 avian-origin H7N9 influenza A virus in : Early findings Jiankui He*, Luwen Ning, Yin Tong Department of Biology, South University of Science and Technology

More information

Purification of viral nucleic acid from serum, plasma, cell-free biological fluids MACHEREY- NAGEL

Purification of viral nucleic acid from serum, plasma, cell-free biological fluids MACHEREY- NAGEL Purification of viral nucleic acid from serum, plasma, cell-free biological fluids Purification of viral nucleic acid from serum, plasma, cell-free biological fluids viral RNA: viral DNA: NucleoSpin RNA

More information

Technical Bulletin No. 161

Technical Bulletin No. 161 CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 161 cobas 6800 HIV-1 Viral Load Assay - New Platform - June 1, 2017 Contact: Heather Habig, MLS (ASCP) CM, MB CM, 717-851-1422 Operations

More information

WHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: VERSANT HIV-1 RNA 1.0 Assay (kpcr) Number: PQDx

WHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: VERSANT HIV-1 RNA 1.0 Assay (kpcr) Number: PQDx WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: VERSANT HIV-1 RNA 1.0 Assay (kpcr) Number: PQDx 0115-041-00 Abstract The VERSANT HIV-1 RNA 1.0 Assay (kpcr) with product codes 10375763,

More information

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Outline Background History of prevention of mother to child

More information

Project PRACE 1IP, WP7.4

Project PRACE 1IP, WP7.4 Project PRACE 1IP, WP7.4 Plamenka Borovska, Veska Gancheva Computer Systems Department Technical University of Sofia The Team is consists of 5 members: 2 Professors; 1 Assist. Professor; 2 Researchers;

More information

INSTRUCTION MANUAL. RNA Clean & Concentrator -5 Catalog Nos. R1015 & R1016. Highlights. Contents

INSTRUCTION MANUAL. RNA Clean & Concentrator -5 Catalog Nos. R1015 & R1016. Highlights. Contents INSTRUCTION MANUAL Catalog Nos. R1015 & R1016 Highlights Quick (5 minute) method for cleaning and concentrating RNA. Ideal for purification of RNA from aqueous phase following an acid phenol extraction.

More information

Models of HIV during antiretroviral treatment

Models of HIV during antiretroviral treatment Models of HIV during antiretroviral treatment Christina M.R. Kitchen 1, Satish Pillai 2, Daniel Kuritzkes 3, Jin Ling 3, Rebecca Hoh 2, Marc Suchard 1, Steven Deeks 2 1 UCLA, 2 UCSF, 3 Brigham & Womes

More information

A Novel Duplex Real-Time Reverse-Transcription PCR Assay for the Detection of Influenza A and the Novel Influenza A(H1N1) Strain

A Novel Duplex Real-Time Reverse-Transcription PCR Assay for the Detection of Influenza A and the Novel Influenza A(H1N1) Strain Viruses 2009, 1, 1204-1208; doi:10.3390/v1031204 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Article A Novel Duplex Real-Time Reverse-Transcription PCR Assay for the Detection of Influenza

More information

BEAST Bayesian Evolutionary Analysis Sampling Trees

BEAST Bayesian Evolutionary Analysis Sampling Trees BEAST Bayesian Evolutionary Analysis Sampling Trees Introduction Revealing the evolutionary dynamics of influenza This tutorial provides a step-by-step explanation on how to reconstruct the evolutionary

More information

Phylodynamics analysis of the Human Immunodeficiency Virus type 1 (HIV-1)

Phylodynamics analysis of the Human Immunodeficiency Virus type 1 (HIV-1) Page 1 of 24 1 Phylodynamics analysis of the Human Immunodeficiency Virus type 1 (HIV-1) envelope gene in mother and child pairs. Luciane Amorim Santos 1, Rebecca R Gray 3, Joana Paixão Monteiro-Cunha

More information

Summary of presentation

Summary of presentation The use of HIV-1 gene sequence data to detect ARV drug resistance mutations and RegaDB database. Tulio de Oliveira Africa Centre for Health and Population Studies, Nelson R Mandela School of Medicine,

More information

SINCE THE INTRODUCTION OF HIGHLY ACTIVE ANTIRETROVIRAL

SINCE THE INTRODUCTION OF HIGHLY ACTIVE ANTIRETROVIRAL AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 23, Number 1, 2007, pp. 107 115 Mary Ann Liebert, Inc. DOI: 10.1089/aid.2006.0089 Investigating Signs of Recent Evolution in the Pool of Proviral HIV Type 1

More information

Balancing investment in point of care diagnostics versus laboratory testing in low resource settings. June 28, 2011

Balancing investment in point of care diagnostics versus laboratory testing in low resource settings. June 28, 2011 Balancing investment in point of care diagnostics versus laboratory testing in low resource settings Workshop on TB and HIV Diagnostics Workshop on TB and HIV Diagnostics June 28, 2011 Complexity Delivery

More information

Dr Graham P Taylor Reader in Communicable Diseases

Dr Graham P Taylor Reader in Communicable Diseases HIV in Pregnancy Joint RCOG/BHIVA Multidisciplinary Conference Dr Graham Taylor Imperial College London Friday 20 January 2012, Royal College of Obstetricians and Gynaecologist, London Prevention of post-partum

More information

Phase II clinical trial TEmAA. Didier Koumavi EKOUEVI, MD PhD (Principal Investigator)

Phase II clinical trial TEmAA. Didier Koumavi EKOUEVI, MD PhD (Principal Investigator) The combination of Tenofovir-Emtricitabine (Truvada ): a new antiretroviral (ARV) regimen for the prevention of mother-to-child transmission of HIV-1 (PMTCT) in resource-limited settings Phase II clinical

More information

Background. A systematic analysis from previous studies reported the following prevalence:

Background. A systematic analysis from previous studies reported the following prevalence: High levels of resistance among HIV-1 treatment naive patients in Greece. a nationwide study: Evidence for country and regional level transmission networks D. Paraskevis 1. E. Kostaki 1. G. Magiorkinis

More information

Validation Report: VERSA Mini PCR Workstation Reverse Transcription of Avian Flu RNA and Amplification of cdna & Detection of H5N1

Validation Report: VERSA Mini PCR Workstation Reverse Transcription of Avian Flu RNA and Amplification of cdna & Detection of H5N1 I. Objectives Validation Report: VERSA Mini PCR Workstation Reverse Transcription of Avian Flu RNA and Amplification of cdna & Detection of H5N1 1. To ensure stability of RNA (highly thermolabile and degradatively

More information

Pelagia Research Library. European Journal of Experimental Biology, 2015, 5(10):1-5

Pelagia Research Library. European Journal of Experimental Biology, 2015, 5(10):1-5 Available online at www.pelagiaresearchlibrary.com European Journal of Experimental Biology, 2015, 5(10):1-5 ISSN: 2248 9215 CODEN (USA): EJEBAU Molecular diagnosis of human immuno deficiency virus (HIV)

More information

HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR

HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR 2015 2020 Presented by Vincent Habiyambere (WHO), Biyi Adesina (Avenir Health) and Meghan Wareham (CHAI) on behalf

More information

Viral Hepatitis Diagnosis and Management

Viral Hepatitis Diagnosis and Management Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents

More information

Evolutionary interactions between haemagglutinin and neuraminidase in avian influenza

Evolutionary interactions between haemagglutinin and neuraminidase in avian influenza Ward et al. BMC Evolutionary Biology 2013, 13:222 RESEARCH ARTICLE Open Access Evolutionary interactions between haemagglutinin and neuraminidase in avian influenza Melissa J Ward 1*, Samantha J Lycett

More information

What Women Need to Know: The HIV Treatment Guidelines for Pregnant Women

What Women Need to Know: The HIV Treatment Guidelines for Pregnant Women : The HIV Treatment Guidelines for Pregnant Women : The HIV Treatment Guidelines for Pregnant Women What Women Need to Know: Prepared by Elaine Gross, RN, MS, CNS-C National Pediatric & Family HIV Resource

More information

The Human Major Histocompatibility Complex

The Human Major Histocompatibility Complex The Human Major Histocompatibility Complex 1 Location and Organization of the HLA Complex on Chromosome 6 NEJM 343(10):702-9 2 Inheritance of the HLA Complex Haplotype Inheritance (Family Study) 3 Structure

More information

SP.718 Special Topics at Edgerton Center: D-Lab Health: Medical Technologies for the Developing World

SP.718 Special Topics at Edgerton Center: D-Lab Health: Medical Technologies for the Developing World MIT OpenCourseWare http://ocw.mit.edu SP.718 Special Topics at Edgerton Center: D-Lab Health: Medical Technologies for the Developing World Spring 2009 For information about citing these materials or our

More information

Exploring HIV Evolution: An Opportunity for Research Sam Donovan and Anton E. Weisstein

Exploring HIV Evolution: An Opportunity for Research Sam Donovan and Anton E. Weisstein Microbes Count! 137 Video IV: Reading the Code of Life Human Immunodeficiency Virus (HIV), like other retroviruses, has a much higher mutation rate than is typically found in organisms that do not go through

More information

TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES

TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES POLICY BRIEF HIV TREATMENT TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES JULY 2017 WHO This policy brief provides advice on a phased approach to transitioning to new WHO-recommended HIV treatment

More information

WHO HIV Drug Resistance Strategy

WHO HIV Drug Resistance Strategy WHO HIV Drug Resistance Strategy Boston, 27 February 2011 Background Global ART scale-up has been a remarkable achievement benefiting over 5.2 million individuals in resource limited settings Maintaining

More information

Obstetrics and HIV An Update. Jennifer Van Horn MD University of Utah

Obstetrics and HIV An Update. Jennifer Van Horn MD University of Utah Obstetrics and HIV An Update Jennifer Van Horn MD University of Utah Obstetrics and HIV Perinatal transmission Testing Antiretroviral therapy Antepartum management Intrapartum management Postpartum management

More information

Rapid Diagnostics CHAI Experience. 6 th Moving Forward in Diagnostics Forum Les Pensieres November 7, 2012

Rapid Diagnostics CHAI Experience. 6 th Moving Forward in Diagnostics Forum Les Pensieres November 7, 2012 Rapid Diagnostics CHAI Experience 6 th Moving Forward in Diagnostics Forum Les Pensieres November 7, 2012 CHAI is working in 12 countries on HIV POC test implementation Kenya Tanzania Ethiopia Malawi Mozambique

More information

Single Cell Quantitative Polymer Chain Reaction (sc-qpcr)

Single Cell Quantitative Polymer Chain Reaction (sc-qpcr) Single Cell Quantitative Polymer Chain Reaction (sc-qpcr) Analyzing gene expression profiles from a bulk population of cells provides an average profile which may obscure important biological differences

More information

An Evolutionary Story about HIV

An Evolutionary Story about HIV An Evolutionary Story about HIV Charles Goodnight University of Vermont Based on Freeman and Herron Evolutionary Analysis The Aids Epidemic HIV has infected 60 million people. 1/3 have died so far Worst

More information

Original article Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South Africa

Original article Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South Africa This pdf is for personal use only. To obtain commercial reprints, Antiviral Therapy 2009 14:975 984 (doi: 10.3851/IMP1416) Original article Prevalence of HIV type-1 drug-associated mutations in pre-therapy

More information

Downloaded from:

Downloaded from: Kiwelu, IE; Novitsky, V; Margolin, L; Baca, J; Manongi, R; Sam, N; Shao, J; McLane, MF; Kapiga, SH; Essex, M (2012) HIV-1 subtypes and recombinants in Northern Tanzania: distribution of viral quasispecies.

More information

Maternal oral CMV recurrence following postnatal primary infection in infants

Maternal oral CMV recurrence following postnatal primary infection in infants Maternal oral CMV recurrence following postnatal primary infection in infants I. Boucoiran, B. T. Mayer, E. Krantz, S. Boppana, A. Wald, L. Corey, C.Casper, J. T. Schiffer, S. Gantt No conflict of interest

More information

Technical Bulletin No. 162

Technical Bulletin No. 162 CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 162 cobas 6800 HCV Viral Load Assay - New Platform - June 1, 2017 Contact: Heather Habig, MLS (ASCP) CM, MB CM, 717-851-1422 Operations

More information

Evolution of hepatitis C virus in blood donors and their respective recipients

Evolution of hepatitis C virus in blood donors and their respective recipients Journal of General Virology (2003), 84, 441 446 DOI 10.1099/vir.0.18642-0 Short Communication Correspondence Jean-François Cantaloube jfc-ets-ap@gulliver.fr Evolution of hepatitis C virus in blood donors

More information

Complicated viral infections

Complicated viral infections Complicated viral infections Clinical case discussion Diagnostic dilemmas NSW State Reference Laboratory for HIV St Vincent s Hospital Sydney Diagnostic dilemmas Indeterminate or discordant serology (western

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Knox DC, Anderson PL, Harrigan PR, Tan DHS. Multidrug-resistant

More information

Student Handout Bioinformatics

Student Handout Bioinformatics Student Handout Bioinformatics Introduction HIV-1 mutates very rapidly. Because of its high mutation rate, the virus will continue to change (evolve) after a person is infected. Thus, within an infected

More information

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital HIV-1 Subtypes: An Overview Anna Maria Geretti Royal Free Hospital Group M Subtypes A (1, 2, 3) B C D F (1, 2) G H J K Mechanisms of HIV-1 genetic diversification Point mutations RT error rate: ~1 per

More information

Pediatric HIV Cure Research

Pediatric HIV Cure Research Pediatric HIV Cure Research HIV Cure Research Training Curriculum Pediatric HIV Cure Research Presented by: Priyanka Uprety,MSPH, PhD Laboratory of Deborah Persaud, MD Johns Hopkins University July 2016

More information

What will happen to these children?

What will happen to these children? The AIDS Epidemic: An Issue for Maternal and Child Health and Nutrition The AIDS Epidemic: An Issue for Maternal and Child Health and Nutrition Kathleen Rasmussen, PhD Professor, Division of Nutritional

More information